EUVIMEDEUVIMED entdecken
Crossref

Monoclonal Gammopathies in Clinical Hematology in Lomé, Togo: Epidemiology and Diagnostic Profile

Womey KM Corcellar, Padaro Essohana, Agate P Raoul, Youssaou Nadiatou, N’dadiya EGM Françoise, Egoli K Justin, Edzolevo A Blessing

Insights in Blood Disorders · 2025

DOI: 10.33425/2771-9073.1016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Insights in Blood Disorders, 2025. Verfasst von Womey KM Corcellar und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: monoclonal gammopathies (MGs) encompass a heterogeneous group of disorders ranging from malignant plasma cell neoplasms to indolent conditions such as MGUS. While extensively characterized in high-income countries, data from sub-Saharan Africa remain scarce. We conducted the first comprehensive study of MGs in Togo to describe their epidemiological and diagnostic features. Methods: we performed a retrospective chart review of patients diagnosed with MGs in the Department of Clinical Hematology at CHU-Campus, Lomé, between June 2011 and April 2024. Inclusion required confirmation of a monoclonal component by serum protein electrophoresis and immunotyping, with complete clinical records available. Data collected included demographics, clinical presentation, laboratory findings, and final diagnosis. Results: Thirty-nine patients were identified, corresponding to an annual incidence of approximately three new cases. The mean age was 60 years (range, 35–75), with a slight female predominance (sex ratio 0.95). Most cases (84.6%) were diagnosed based on clinical manifestations, whereas only 11.3% were detected incidentally. IgG was the predominant heavy-chain isotype (89.7%), most frequently associated with kappa light chains (56.4%). Multiple myeloma accounted for 82.1% of diagnoses, followed by MGUS (12.8%) and Waldenström’s macroglobulinemia (5.1%). Conclusion: in this first series from Togo, MGs were most often diagnosed at a symptomatic stage, with multiple myeloma predominating and MGUS rarely identified. The predominance of IgG-kappa is consistent with global trends, but the scarcity of asymptomatic cases highlights underrecognition and limited screening in resource-limited settings. Expanding diagnostic capacity and awareness is essential to improve early detection and patient outcomes in West Africa.

Zitieren

APA

Corcellar, W. K., Essohana, P., Raoul, A. P., Nadiatou, Y., Françoise, N. E., Justin, E. K., & Blessing, E. A. (2025). Monoclonal Gammopathies in Clinical Hematology in Lomé, Togo: Epidemiology and Diagnostic Profile. Insights in Blood Disorders. https://doi.org/10.33425/2771-9073.1016

Vancouver

Corcellar WK, Essohana P, Raoul AP, Nadiatou Y, Françoise NE, Justin EK, et al. Monoclonal Gammopathies in Clinical Hematology in Lomé, Togo: Epidemiology and Diagnostic Profile. Insights in Blood Disorders. 2025. doi:10.33425/2771-9073.1016

BibTeX
@article{Corcellar2025,
  author = {Corcellar, Womey KM and Essohana, Padaro and Raoul, Agate P and Nadiatou, Youssaou and Françoise, N’dadiya EGM and Justin, Egoli K and Blessing, Edzolevo A},
  title = {Monoclonal Gammopathies in Clinical Hematology in Lomé, Togo: Epidemiology and Diagnostic Profile},
  journal = {Insights in Blood Disorders},
  year = {2025},
  doi = {10.33425/2771-9073.1016}
}
Kostenlos starten →